FDA

• 11/19/2024

  “Unlocking the $400 Billion BCI Boom: The Future of Human Connection”

• 11/10/2024

  Abortion Rights in Peril: What’s at Stake in the US

• 11/10/2024

  “FDA Targets Ineffective Cold Medicine Ingredient: What You Need to Know”

• 11/9/2024

  Vaccine Skepticism Threatens Healthcare: The Risks of Misinformation

• 11/6/2024

  Abortion Rights on the Line: The 2024 Presidential Election

• 11/4/2024

  Wegovy and Ozempic Now Fully Available in US: Novo Nordisk Resolves Supply Chain Issues

• 11/4/2024

  Bristol Myers Squibb Smashes Q3 Earnings Expectations

• 11/1/2024

  Eli Lilly’s Q3 Earnings Disappoint: Sales of Blockbuster Drugs Fall Short

• 10/27/2024

• 10/22/2024

  Annovis Bio’s Phase 3 Trials: Can They Secure Funding?